Immune response to revaccination with meningococcal A and C polysaccharides in Gambian children following repeated immunisation during early childhood

Vaccine

Volumn 17, Issue 23-24, 1999, Pages 3086-3093

  MacLennan, Jenny ^a   Obaro, Stephen ^c   Deeks, Jonathan ^a   Williams, Derrick ^c   Pais, Lorna ^c   Carlone, George ^c   Moxon, Richard ^a   Greenwood, Brian ^b  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^c Dept of Infect and Trop Diseases Sch of Hyg and Tropical Medicine ^*

Author keywords

Meningococcus; Polysaccharide vaccine; Tolerance

Indexed keywords

MENGIVAC; MENINGOCOCCUS VACCINE; UNCLASSIFIED DRUG;

ANTIBODY DETECTION; ANTIBODY TITER; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG EFFICACY; EPIDEMIC MENINGITIS; GAMBIA; HUMAN; IMMUNE RESPONSE; INTRAMUSCULAR DRUG ADMINISTRATION; NEISSERIA MENINGITIDIS; PRESCHOOL CHILD; PRIORITY JOURNAL; REVACCINATION;

EID: 0033529658     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0264-410X(99)00139-5     Document Type: Article

References (25)

1. Evans Jones L.G., Whittle H.C., Onyewotu I.I., Egler L.J., Greenwood B.M. Comparative study of group A and group C meningococcal infection. Archives of Disease in Childhood. 52:1977;320-323.
2. Broome C.V., Rugh M.A., Yada A.A., Giat L., Giat H., Zeltner J.M., Sanborn W.R., Fraser D.W. Epidemic group C meningococcal meningitis in Upper Volta, 1979. Bulletin of the World Health Organisation. 61:1983;325-330.
3. Response to epidemic meningitis in Africa. Weekly Epidemiological Record 72:313-320 1997.
4. Robbins J.B., Towne D.W., Gotschlich E.C., Schneerson R. 'Love's labours lost': failure to implement mass vaccination against group A meningococcal meningitis in sub-Saharan Africa. Lancet. 350:1997;880-882.
5. Twumasi P.A., Kumah S., Leach A., O'Dempsey J.D., Ceesay S.J., Todd J.E., Broome C.V., Carlone G.M., Pais L.B., Holder P.K., Plikaytis B.D., Greenwood B.M. A trial of a group A plus group C meningococcal polysaccharide-protein conjugate vaccine in African infants. Journal of Infectious Diseases. 171:1995;632-638.
6. Leach A., Twumasi P.A., Kumah S., Banya W.S., Jaffar S., Forrest B.D., Granoff D.M., LiButti D.E., Carlone G.M., Pais L.B., Broome C.V., Greenwood B.M. Induction of immunologic memory in Gambian children by vaccination in infancy with a group A plus group C meningococcal polysaccharide-protein conjugate vaccine. Journal of Infectious Diseases. 175:1997;200-204.
7. Gheesling L.L., Carlone G.M., Pais L.B., Holder P.F., Maslanka S.E., Plikaytis B.D., Achtman M., Densen P., Frasch C.E., Kayhty H., et al. Multicenter comparison of Neisseria meningitidis serogroup C anti-capsular polysaccharide antibody levels measured by a standardized enzyme-linked immunosorbent assay. Journal of Clinical Microbiology. 32:1994;1475-1482.
8. Carlone G.M., Frasch C.E., Siber G.R., Quataert S., Gheesling L.L., Turner S.H., Plikaytis B.D., Helsel L.O., DeWitt W.E., Bibb W.F., et al. Multicenter comparison of levels of antibody to the Neisseria meningitidis group A capsular polysaccharide measured by using an enzyme-linked immunosorbent assay. Journal of Clinical Microbiology. 30:1992;154-159.
9. Holder P.K., Maslanka S.E., Pais L.B., Dykes J., Plikaytis B.D., Carlone G.M. Assignment of Neisseria meningitidis serogroup A and C class- specific anticapsular antibody concentrations to the new standard reference serum CDC1992. Clin. Diagn. Lab. Immunol. 2:1995;132-137.
10. Maslanka S.E., Gheesling L.L., LiButti D.E., Donaldson K.B., Harakeh H.S., Dykes J.K., Arhin F.F., Devi S.J., Frasch C.E., Huang J.C., Kriz Kuzemenska P., Lemmon R.D., Lorange M., Peeters C.C., Quataert S., Tai J.Y., Carlone G.M. Standardization and a multilaboratory comparison of Neisseria meningitidis serogroup A and C serum bactericidal assays. The Multilaboratory Study Group. Clin. Diagn. Lab. Immunol. 4:1997;156-167.
11. Stata Corporation 1997 Stata Statistical Software: Release 5.0 College station, TX.
12. Maslanka S.E., Tappero J.W., Plikaytis B.D., Brumberg R.S., Dykes J.K., Gheesling L.L., Donaldson K.B., Schuchat A., Pullman J., Jones M., Bushmaker J., Carlone G.M. Age-dependent Neisseria meningitidis serogroup C class-specific antibody concentrations and bactericidal titers in sera from young children from Montana immunized with a licensed polysaccharide vaccine. Infection and Immunity. 66:1998;2453-2459.
13. Lieberman J.M., Wong V.K., Partridge S., Chang S.J., Gheesling L.L., Carlone G.M., Ward J.I. Bivalent A/C meningococcal conjugate vaccine in toddlers: persistence of antibodies and response to a polysaccharide vaccine booster (Poster 75). Abstracts of the 10th Neisseria Meeting, Baltimore. 1996;231-232.
14. Nieminen T., Kayhty H., Kantele A. Circulating antibody secreting cells and humoral antibody response after parenteral immunization with a meningococcal polysaccharide vaccine. Scandinavian Journal of Infectious Diseases. 28:1996;53-58.
15. Granoff DM, Gupta RK, Belshe RB, Anderson EL Induction of immunologic tolerance in adults by meningococcal C polysaccharide vaccination (Abstract 417). Clinics in Infectious Diseases, 432. 1997.
16. MacDonald N.E., Halperin S., Law B., Forrest B.D., Mokatrin A.S., Granoff D.M. Immunisation of toddlers with chiron meningococcal C (men C) vaccine induces immunologic memory while plain meningococcal polysaccharide (PS) vaccine induces tolerance (Abstract G-3). Abstracts of the 37th Interscience Conference on Antimicrobial Agents and Chemotherapy (Toronto, Canada). 1997;192.
17. Gold R., Lepow M.L., Goldschneider I., Gotschlich E.C. Immune response of human infants of polysaccharide vaccines of group A and C Neisseria meningitidis. Journal of Infectious Diseases. 136:(Suppl):1977;S31-S35.
18. Kayhty H., Karanko V., Peltola H., Sarna S., Makela H. Serum antibodies to capsular polysaccharide vaccine of group A Neisseria meningitidis followed for three years in infants and children. The Journal of Infectious Diseases. 142:1980;861-868.
19. Gold R., Lepow M.L., Goldschneider I., Draper T.F., Gotshlich E.C. Kinetics of antibody production to group A and group C meningococcal polysaccharide vaccines administered during the first six years of life: prospects for routine immunization of infants and children. Journal of Infectious Diseases. 140:1979;690-697.
20. Gold R., Lepow M.L., Goldschneider I., Draper T.L., Gotschlich E.C. Clinical evaluation of group A and group C meningococcal polysaccharide vaccines in infants. Journal of Clinical Investigation. 56:1975;1536-1547.
21. Monto A.S., Brandt B.L., Artenstein M.S. Response of children to Neisseria meningitidis polysaccharide vaccines. Journal of Infectious Diseases. 127:1973;394-400.
22. Goldschneider I., Gotschlich E.C., Artenstein M.S. Human immunity to the meningococcus. I. The role of humoral antibodies. J. Exp. Med. 129:1969;1307-1326.
23. Fairley C.K., Begg N., Borrow R., Fox A.J., Jones D.M., Cartwright K. Conjugate meningococcal serogroup A and C vaccine: reactogenicity and immunogenicity in United Kingdom infants. Journal of Infectious Diseases. 174:1996;1360-1363.
24. Maclennan J.M., Shackley F., Heath P.T. Induction of immunological memory by a Neisseria meningitidis group C conjugate vaccine (Abstract O19). Abstracts of the 15th Annual Meeting of the European Society of Paediatric Infectious Diseases, Paris, France. 1997;10.
25. Campagne G., Garber A., Fabre P. Safety and immunogenicity of three doses of an N. meningiitidis A/C diphtheria conjugate vaccine in infants in Niger (Abstract G-1). Abstracts of the 37th Interscience Conference on Antimicrobial Agents and Chemotherapy (Toronto, Canada). 1997;192.